Immunophenotypic analysis of human CD45+ cells showed high expression of myeloid markers (CD33+) and low expression of lymphoid markers (CD3+, CD19+) confirming a diagnosis of AML (Figure 4D). The gene discussed is CD19; the disease is acute myeloid leukemia.